Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Share-based Compensation (2019 - 2025)

AdaptHealth has reported Share-based Compensation over the past 7 years, most recently at $5.1 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $5.1 million for Q4 2025, up 20.44% from a year ago — trailing twelve months through Dec 2025 was $21.9 million (up 47.02% YoY), and the annual figure for FY2025 was $21.9 million, up 47.02%.
  • Share-based Compensation for Q4 2025 was $5.1 million at AdaptHealth, down from $5.3 million in the prior quarter.
  • Over the last five years, Share-based Compensation for AHCO hit a ceiling of $8.6 million in Q1 2021 and a floor of $863000.0 in Q3 2024.
  • Median Share-based Compensation over the past 5 years was $5.4 million (2021), compared with a mean of $5.3 million.
  • Biggest five-year swings in Share-based Compensation: surged 2760.67% in 2021 and later crashed 80.91% in 2024.
  • AdaptHealth's Share-based Compensation stood at $3.9 million in 2021, then skyrocketed by 42.86% to $5.6 million in 2022, then fell by 7.64% to $5.2 million in 2023, then dropped by 17.71% to $4.3 million in 2024, then increased by 20.44% to $5.1 million in 2025.
  • The last three reported values for Share-based Compensation were $5.1 million (Q4 2025), $5.3 million (Q3 2025), and $6.1 million (Q2 2025) per Business Quant data.